-
Roth Capital Downgrades Regeneron Pharma to Neutral
Tuesday, January 17, 2012 - 9:12amRoth Capital has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN) to Neutral.
Read More >> -
Roth Capital Upgrades Celldex Therapeutics to Buy
Tuesday, January 17, 2012 - 8:31amRoth Capital has upgraded Celldex Therapeutics (NASDAQ: CLDX) to Buy.
Read More >> -
Roth Capital Upgrades Hollysys Automation to Buy
Thursday, December 29, 2011 - 8:10amRoth Capital has upgraded Hollysys Automation (NASDAQ: HOLI) to Buy.
Read More >> -
Roth Capital Downgrades VIVUS to Neutral
Thursday, December 22, 2011 - 8:17amRoth Capital has downgraded VIVUS (NASDAQ: VVUS) to Neutral with an $11.50 price target.
Read More >> -
Roth Capital Downgrades inContact to Neutral
Monday, December 19, 2011 - 8:19amRoth Capital has downgraded inContact (NASDAQ: SAAS) to Neutral, $5 PT.
Read More >> -
Roth Capital Downgrades Pegasystems to Neutral
Monday, December 19, 2011 - 8:18amRoth Capital has downgraded Pegasystems (NASDAQ: PEGA) to Neutral, $35 PT.
Read More >> -
Hearing Informatica Downgraded to Hold at Roth Capital
Friday, October 21, 2011 - 6:19am -
Hearing Shanda Interactive Upgraded to Neutral at Roth Capital
Monday, October 17, 2011 - 11:15am -
Roth Capital Downgraded Hollysys Automaton from Buy to Neutral
Monday, July 25, 2011 - 6:57am -
Roth Capital Downgrades Uroplasty To Neutral
Wednesday, July 20, 2011 - 8:59amRoth Capital has downgraded Uroplasty (NASDAQ: UPI) from Buy to Neutral.
Read More >>
